J Pain Symptom Manage. 1990 Feb;5(1):33-41.

Subcutaneous infusions for control of cancer symptoms.

Storey P, Hill HH Jr, St Louis RH, Tarver EE.

Abstract

Continuous subcutaneous infusions offer a safe, simple, effective alternative to intravenous or intramuscular injections when oral medications cannot be used. They are extremely useful for cancer patients suffering from pain, vomiting, seizures, and other symptoms. Hydromorphone or morphine may be combined with metoclopramide, methotrimeprazine, or haloperidol (in D5W only), in the same pump to control both pain and nausea. Seizures can be controlled by subcutaneous infusion of phenobarbital or midazolam. If proper doses are prescribed and skin irritation is watched for, they can be used safely in the patient's home.

PMID:: 1969887; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Education

New England Research Institutes Inc.

Medical

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Review Treatment of intractable cancer pain by electronically controlled parenteral infusion of analgesic drugs. [Cancer. 1993]
Review Treatment of intractable cancer pain by electronically controlled parenteral infusion of analgesic drugs.
Shaw HL. Cancer. 1993 Dec 1; 72(11 Suppl):3416-25.
Use of the subcutaneous route for the administration of narcotics in patients with cancer pain. [Cancer. 1988]
Use of the subcutaneous route for the administration of narcotics in patients with cancer pain.
Bruera E, Brenneis C, Michaud M, Bacovsky R, Chadwick S, Emeno A, MacDonald N. Cancer. 1988 Jul 15; 62(2):407-11.
Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain. [Lancet. 1991]
Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain.
Moulin DE, Kreeft JH, Murray-Parsons N, Bouquillon AI. Lancet. 1991 Feb 23; 337(8739):465-8.
A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids. [Cancer. 2002]
A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids.
Enting RH, Oldenmenger WH, van der Rijt CC, Wilms EB, Elfrink EJ, Elswijk I, Sillevis Smitt PA. Cancer. 2002 Jun 1; 94(11):3049-56.
Review Current status of patient-controlled analgesia in cancer patients. [Oncology (Williston Park). 1997]
Review Current status of patient-controlled analgesia in cancer patients.
Ripamonti C, Bruera E. Oncology (Williston Park). 1997 Mar; 11(3):373-80, 383-4; discussion 384-6.

See reviews... See all...

Cited by 4 PubMed Central articles

An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS(R) hydromorphone in patients with chronic cancer pain. [BMC Palliat Care. 2009]
An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS(R) hydromorphone in patients with chronic cancer pain.
Hanna M, Tuca A, Thipphawong J. BMC Palliat Care. 2009 Sep 15; 8:14. Epub 2009 Sep 15.
Once-daily OROS hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study. [Int J Clin Pract. 2007]
Once-daily OROS hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study.
Wallace M, Rauck RL, Moulin D, Thipphawong J, Khanna S, Tudor IC. Int J Clin Pract. 2007 Oct; 61(10):1671-6.
Plasma concentrations of fentanyl with subcutaneous infusion in palliative care patients. [Br J Clin Pharmacol. 1995]
Plasma concentrations of fentanyl with subcutaneous infusion in palliative care patients.
Miller RS, Peterson GM, Abbott F, Maddocks I, Parker D, McLean S. Br J Clin Pharmacol. 1995 Dec; 40(6):553-6.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Subcutaneous infusions for control of cancer symptoms.
Subcutaneous infusions for control of cancer symptoms.
J Pain Symptom Manage. 1990 Feb ;5(1):33-41.

PubMed
Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when tre...
Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study.
BMC Med. 2009 Aug 24 ;7:41.

PubMed
Mammalian hibernation.
Mammalian hibernation.
Philos Trans R Soc Lond B Biol Sci. 1990 Jan 30 ;326(1237):669-85, discussion 685-6.

PubMed
Cooperative action of TIP48 and TIP49 in H2A.Z exchange catalyzed by acetylation...
Cooperative action of TIP48 and TIP49 in H2A.Z exchange catalyzed by acetylation of nucleosomal H2A.
Nucleic Acids Res. 2009 Oct ;37(18):5993-6007. Epub 2009 Aug 20 .

PubMed
Trends in schizophrenia.
Trends in schizophrenia.
Lancet. 1990 Apr 7 ;335(8693):851-3.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: